PGEN - CIK 0001356090
PRECIGEN, INC. trades as PGEN and has a market capitalization of $1.38 B, making it the #2403 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $9.68M, up 146.7% from the prior year and net income of -$250.60M. This page tracks PRECIGEN, INC. through 1,273 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years PRECIGEN, INC.'s revenue declined from $190.93M to $9.68M, a compound annual decline rate of 28.2%. Net profit margin compressed from -97.7% to -2587.8% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-13 |
| Major company event | 8-K | 2026-05-13 |
| Annual report to shareholders | ARS | 2026-04-30 |
| Proxy materials | DEFA14A | 2026-04-30 |
| Proxy statement | DEF 14A | 2026-04-30 |
| Insider trade | 4 | 2026-04-22 |
| Insider trade | 4 | 2026-04-22 |
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years | Precigen
Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States | Precigen
Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference | Precigen
Precigen Reports First Quarter 2026 Financial Results and Business Updates | Precigen
Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13 | Precigen
The largest companies sharing PRECIGEN, INC.'s SEC industry classification (pharmaceutical preparations).
PRECIGEN, INC. (PGEN) has a market capitalization of $1.38 B as of 2026-06-10, ranking #2403 among US-listed companies.
PRECIGEN, INC. reported revenue of $9.68M for fiscal year 2025, an increase of 146.7% year over year.
In its latest fiscal year PRECIGEN, INC. reported a net loss of $250.60M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.